Protein Engineering

Optimising pharmaceutical properties

Natural proteins often have attractive activities with therapeutic potential but they may not possess ideal pharmaceutical properties. Improvements in stability, selectivity, pharmacokinetics and formulation can be achieved through protein engineering. CBV has experience of developing strategies to improve the properties of proteins to produce an ideal biopharmaceutical product

MIP-1a

NMR structure of BB-10010 from Czaplewski et al.
Graphic prepared using PyMol.

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.


Get Flash Player